← FDA DRUG APPROVALS

FDA NDA · NDA020988

PROTONIX I.V.

pantoprazole sodium

Sponsor: WYETH PHARMS

APPLICATION
NDA020988
TYPE
NDA
ORIGINAL APPROVAL
2001-03-22
LATEST ACTION
2024-08-12
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

PROTONIX IV · ReferencePrescription
PANTOPRAZOLE SODIUM EQ 40MG BASE/VIAL · INJECTABLE · INTRAVENOUS

Approval history

2024-08-12Efficacy · Supplement 70 · standardLabelAP
2023-07-18Labeling · Supplement 69 · standardLetterAP
2022-03-04Labeling · Supplement 64 · standardLetterAP
2020-11-27Labeling · Supplement 62 · standardLabelAP
2019-04-25Labeling · Supplement 61 · standardLetterAP
2018-06-07Labeling · Supplement 60 · standardLabelAP
2017-12-20Labeling · Supplement 55 · standardLabelAP
2017-12-06Labeling · Supplement 58 · standardLabelAP
2017-07-06Labeling · Supplement 59 · standardLabelAP
2016-10-24Labeling · Supplement 54 · standardLetterAP
2015-11-09Manufacturing (CMC) · Supplement 53 · standardAP
2014-12-19Labeling · Supplement 52 · 901 requiredLetterAP
2014-11-05Manufacturing (CMC) · Supplement 51 · standardAP
2014-09-26Manufacturing (CMC) · Supplement 50 · standardAP
2014-09-26Manufacturing (CMC) · Supplement 49 · standardAP
2014-03-04Manufacturing (CMC) · Supplement 47 · standardAP
2013-12-12Labeling · Supplement 48 · standardLetterAP
2012-09-28Labeling · Supplement 44 · standardLetterAP
2012-05-10Labeling · Supplement 45 · standardLabelAP
2011-12-07Labeling · Supplement 42 · unknownLetterAP
2011-06-07Labeling · Supplement 41 · unknownLabelAP
2011-05-20Labeling · Supplement 43 · unknownLetterAP
2010-09-03Labeling · Supplement 40 · unknownLetterAP
2007-12-20Labeling · Supplement 38 · standardLetterAP
2005-08-03Manufacturing (CMC) · Supplement 32 · standardLetterAP
2005-08-02Labeling · Supplement 31 · standardLabelAP
2004-12-06Supplement · Original · standardAP
2004-12-06Efficacy · Supplement 27 · unknownLabelAP
2004-11-18Labeling · Supplement 28 · standardLetterAP
2004-10-28Manufacturing (CMC) · Supplement 29 · standardLetterAP
2004-05-05Labeling · Supplement 19 · standardLabelAP
2004-04-02Manufacturing (CMC) · Supplement 24 · standardLetterAP
2004-04-02Labeling · Supplement 25 · standardLabelAP
2004-03-05Labeling · Supplement 15 · standardLetterAP
2004-01-09Labeling · Supplement 20 · standardLabelAP
2004-01-02Labeling · Supplement 21 · standardLetterAP
2003-11-18Labeling · Supplement 17 · standardLabelAP
2003-10-24Labeling · Supplement 16 · standardLetterAP
2003-02-21Labeling · Supplement 7 · standardLetterAP
2002-12-04Manufacturing (CMC) · Supplement 14 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →